Detalhe da pesquisa
1.
Immunogenicity of quadrivalent meningococcal conjugate vaccine in frequent platelet donors.
Blood
; 142(2): 202-209, 2023 07 13.
Artigo
Inglês
| MEDLINE | ID: mdl-37172200
2.
First-in-Human Randomized, Controlled Trial of Mosaic HIV-1 Immunogens Delivered via a Modified Vaccinia Ankara Vector.
J Infect Dis
; 218(4): 633-644, 2018 07 13.
Artigo
Inglês
| MEDLINE | ID: mdl-29669026
3.
Induction of HIV-1-specific mucosal immune responses following intramuscular recombinant adenovirus serotype 26 HIV-1 vaccination of humans.
J Infect Dis
; 211(4): 518-28, 2015 Feb 15.
Artigo
Inglês
| MEDLINE | ID: mdl-25165165
4.
First-in-human evaluation of a hexon chimeric adenovirus vector expressing HIV-1 Env (IPCAVD 002).
J Infect Dis
; 210(7): 1052-61, 2014 Oct 01.
Artigo
Inglês
| MEDLINE | ID: mdl-24719474
5.
Safety and immunogenicity of modified vaccinia Ankara in hematopoietic stem cell transplant recipients: a randomized, controlled trial.
J Infect Dis
; 207(12): 1888-97, 2013 Jun 15.
Artigo
Inglês
| MEDLINE | ID: mdl-23482644
6.
Effect of vaccination with modified vaccinia Ankara (ACAM3000) on subsequent challenge with Dryvax.
J Infect Dis
; 201(9): 1353-60, 2010 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-20350190
7.
Safety and immunogenicity of modified vaccinia Ankara (ACAM3000): effect of dose and route of administration.
J Infect Dis
; 201(9): 1361-70, 2010 May 01.
Artigo
Inglês
| MEDLINE | ID: mdl-20350191